List of articles by "Health"

Edgewise Q2 2025 Review

Edgewise Q2 2025 Review

United States Boulder Edgewise Therapeutics Sevasemten Becker muscular dystrophy
K36 Therapeutics FDA Approval

K36 Therapeutics FDA Approval

USA Cambridge K36 Therapeutics Prostate Cancer KTX-2001
MAX-001 IND Submission

MAX-001 IND Submission

United States FDA Approval Malvern MAX-001 MAXONA
Curve Dental FLO AI

Curve Dental FLO AI

USA Alpharetta Dental Software Curve Dental FLO AI
Cortium Launch

Cortium Launch

USA Plano ulrich medical Cortium Spinal Fixation
Aktis Oncology Welcomes Sherman

Aktis Oncology Welcomes Sherman

United States Boston Aktis Oncology Oncology Leadership Mike Sherman
Q2 2025 Financial Highlights

Q2 2025 Financial Highlights

United States Morristown, NJ Whitehawk Therapeutics ADC treatments oncology company
Collaboration to Improve ASCs

Collaboration to Improve ASCs

USA Dallas SYNERGEN Health Compass Surgical ASC Operations
Creyos Cognitive Health

Creyos Cognitive Health

Canada Toronto cognitive health Creyos Adrian Owen
FDA Approval for Embrace

FDA Approval for Embrace

United States Bedford Interventional Radiology Instylla Embrace Hydrogel
Undiagnosed OSA Symptoms

Undiagnosed OSA Symptoms

USA Littleton Obstructive Sleep Apnea Vivos Therapeutics OSA Symptoms
ARTBIO Board Expansion

ARTBIO Board Expansion

United States Cambridge ARTBIO Alpha Radioligand Roy Larsen
REGENXBIO Q2 2025 Update

REGENXBIO Q2 2025 Update

USA Rockville gene therapy Clinical Trials REGENXBIO
Dr. Lahr Joins uPerform

Dr. Lahr Joins uPerform

None Health IT uPerform Dr. Lahr Elkridge
Insmed Q2 2025 Revenue

Insmed Q2 2025 Revenue

United States Bridgewater Insmed ARIKAYCE brensocatib
Pivotal Trial for DR

Pivotal Trial for DR

United States Rockville REGENXBIO Diabetic Retinopathy Surabgene Lomparvovec
Voice Care This School Year

Voice Care This School Year

United States Rockville American Speech-Language-Hearing Association voice health vocal tips
Eli Lilly Q2 2025 Insights

Eli Lilly Q2 2025 Insights

United States Indianapolis Zepbound Eli Lilly Mounjaro
Nuvalent Q2 2025 Summary

Nuvalent Q2 2025 Summary

USA Cambridge zidesamtinib Neladalkib Nuvalent Inc
Immunic's Q2 Results

Immunic's Q2 Results

USA New York Multiple Sclerosis Immunic Vidofludimus Calcium
Zimmer Biomet Q2 Growth

Zimmer Biomet Q2 Growth

United States financial results Warsaw Zimmer Biomet Q2 2025
AI Boosts Behavioral Health Access

AI Boosts Behavioral Health Access

United States New York Pager Health Health Services AI Behavioral Health
Lilly's Orforglipron Results

Lilly's Orforglipron Results

United States Indianapolis weight loss Eli Lilly Orforglipron
Elanco Q2 2025 Results

Elanco Q2 2025 Results

United States Elanco Animal Health financial results Greenfield Credelio Quattro
Audien Hearing Expansion

Audien Hearing Expansion

United States Scottsdale Walgreens Hearing Aids Audien Hearing
Psilocybin Law in NM

Psilocybin Law in NM

USA mental health Roswell Psilocybin Law Trent Carter
Harlem Legionnaires' Disease

Harlem Legionnaires' Disease

United States New York Legionnaires' Disease Legal Representation Harlem
Minghui Pharmaceutical Funding

Minghui Pharmaceutical Funding

China Shanghai Minghui Pharmaceutical Qiming Venture Partners OrbiMed
Haemonetics Q1 Results

Haemonetics Q1 Results

United States Boston earnings report Haemonetics fiscal year 2026
Antares Vision in Africa

Antares Vision in Africa

None pharmaceutical Supply Chain Antares Vision
Antares Vision Africa

Antares Vision Africa

None Antares Vision African Pharmaceuticals Track & Trace
Healthcare Devices Exposed

Healthcare Devices Exposed

Cybersecurity Netherlands The Hague Healthcare Devices Modat
Family Site in Poco'ce

Family Site in Poco'ce

Japan Tokyo Bespra Family Site Poco'ce
M3 Releases COVID-19 Report

M3 Releases COVID-19 Report

Japan Tokyo COVID-19 Japan Health M3 Research Institute
Cooling Shelter Launch

Cooling Shelter Launch

Japan Cooling Shelter Suginami Suginami Ward Tomoz
Advancing Cancer Treatment

Advancing Cancer Treatment

United States San Diego Senhwa Biosciences MYC Lymphoma CX-5461
5-Year RefluxStop Results

5-Year RefluxStop Results

Liechtenstein Vaduz Implantica GERD RefluxStop
Kokoromil Selected

Kokoromil Selected

Japan Tokyo ECG technology Home Heart Dock Kokoromil
UDENYCA Acquisition

UDENYCA Acquisition

India Accord BioPharma UDENYCA Ahmedabad Pegfilgrastim
Fujifilm & Horiba Collaboration

Fujifilm & Horiba Collaboration

Japan Tokyo gene therapy Fujifilm HORIBA
NemieluLight Launch

NemieluLight Launch

Japan Health Management Tokyo Sleep Tech Nemiel
Herbal Remedies Show

Herbal Remedies Show

Japan Tokyo Kanpo Therapy Kracie Pharmaceuticals Women’s Health
SMARTOne Revamped

SMARTOne Revamped

Japan healthcare technology Tokyo GENOVA SMARTOne
ZIP! Exercise

ZIP! Exercise

Japan Tokyo Tipness ZIP! Exercise Health Routine
Loxonin PRO Physical

Loxonin PRO Physical

Japan Daiichi Sankyo Tokyo Pain Relief Loxonin
Sado's Healthcare Boost

Sado's Healthcare Boost

Japan Matchbox Technologies Sado Sado City Sado General Hospital
Health Insurance Survey

Health Insurance Survey

Japan Tokyo Senior Care Health Insurance Sugawara Yuichi
Home Medical Report 2025

Home Medical Report 2025

Japan Tokyo MedicalInformatics HomeMedical HealthcareReport
New Gym in Ontakesan

New Gym in Ontakesan

Gym Pilates Personal Training Ota
Summer Fatigue Survey

Summer Fatigue Survey

Japan Tokyo Nutrition Asuken summer fatigue

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.